Table 3.
KEGG pathway analysis for the differentially expressed genes in ceRNA network (top 20 and P-Value < 0.05).
| KEGG pathway | KEGG entry | Count | P-value |
|---|---|---|---|
| Ras signaling pathway | hsa04014 | 5 | 0.00150489 |
| Signaling pathways regulating pluripotency of stem cells | hsa04550 | 4 | 0.001715907 |
| MicroRNAs in cancer | hsa05206 | 4 | 0.025390161 |
| PI3K-Akt signaling pathway | hsa04151 | 4 | 0.038726252 |
| Lysine degradation | hsa00310 | 3 | 0.001518792 |
| p53 signaling pathway | hsa04115 | 3 | 0.002320839 |
| FoxO signaling pathway | hsa04068 | 3 | 0.011847299 |
| Breast cancer | hsa05224 | 3 | 0.016137167 |
| Cushing syndrome | hsa04934 | 3 | 0.018570745 |
| mTOR signaling pathway | hsa04150 | 3 | 0.018888609 |
| Transcriptional misregulation in cancer | hsa05202 | 3 | 0.032799945 |
| Focal adhesion | hsa04510 | 3 | 0.036357529 |
| Epstein-Barr virus infection | hsa05169 | 3 | 0.036815855 |
| Proteoglycans in cancer | hsa05205 | 3 | 0.03820893 |
| Aldosterone-regulated sodium reabsorption | hsa04960 | 2 | 0.007978151 |
| Vasopressin-regulated water reabsorption | hsa04962 | 2 | 0.011154062 |
| Longevity regulating pathway - Multiple species | hsa04213 | 2 | 0.021407799 |
| Prolactin signaling pathway | hsa04917 | 2 | 0.026851559 |
| Melanoma | hsa05218 | 2 | 0.02829165 |
| Platinum drug resistance | hsa01524 | 2 | 0.029023222 |